\begin{table}[!h]
\centering
\caption{\label{tab:tab:study_characteristics_aggregated}Study-level characteristics by molecule: studies, participants, active dose range, and windows. Placebo substances are illustrative examples aggregated per study.}
\centering
\begin{tabular}[t]{lrrr>{\raggedright\arraybackslash}p{2.5cm}rl>{\raggedright\arraybackslash}p{3.2cm}>{\raggedright\arraybackslash}p{3.2cm}}
\toprule
Molecule & Studies & Participants (unique/study) & Participants (arms sum) & Dose range (mg, active) & \# active doses & Windows & Inactive placebo subs. & Active placebo subs.\\
\midrule
\cellcolor{gray!10}{AYAHUASCA} & \cellcolor{gray!10}{2} & \cellcolor{gray!10}{24} & \cellcolor{gray!10}{46} & \cellcolor{gray!10}{0.36–0.36} & \cellcolor{gray!10}{1} & \cellcolor{gray!10}{Session / —} & \cellcolor{gray!10}{inactive} & \cellcolor{gray!10}{inactive}\\
LSD & 6 & 234 & 1036 & 0.10–200.00 & 8 & Session / Follow-up & inactive & inactive, LSD\\
\cellcolor{gray!10}{MDMA} & \cellcolor{gray!10}{10} & \cellcolor{gray!10}{215} & \cellcolor{gray!10}{539} & \cellcolor{gray!10}{75.00–150.00} & \cellcolor{gray!10}{5} & \cellcolor{gray!10}{Session / Follow-up} & \cellcolor{gray!10}{inactive, lacose, lactose} & \cellcolor{gray!10}{inactive, lacose, lactose, MDMA}\\
PSILOCYBIN & 9 & 320 & 696 & 10.00–40.00 & 3 & Session / — & diphenhydramine, mannitol & diphenhydramine, mannitol, niacin, psilocybin\\
\bottomrule
\end{tabular}
\end{table}
